Mga Serbisyo sa CQDMO

To resolve the core technical issues of cellular therapy and accelerate the industrialization efficiency of medicine from the source, Hillgene independently researched and developed a serial of technical platforms for cellular therapy, including industrialization of nucleic acid (plasmid/mRNA), HiLenti®- T lentiviral vector system, hilenti®- NK Lentiviral Vector System, Hilenti®- serum - libre nga pagsuspinde nga kultura sa mga tumento nga mga vectors, hicellx®- hingpit nga sirado nga proseso sa proseso alang sa mga cellular nga produkto, ug hicellx® Stem - dako - sukod sa paghimo sa mga stem cells. With these independently developed technical platforms, we can offer our clients one-stop CDMO services for cellular therapy, thereby contributing to making more products to the next milestone sooner and faster.